Course Unit / Trading models for market access

Trading models for market access

Year
1
Academic year
2024-2025
Code
02046510
Subject Area
Pharmaceutical Sciences
Language of Instruction
Portuguese
Mode of Delivery
B-learning
Duration
SEMESTRIAL
ECTS Credits
5.0
Type
Compulsory
Level
2nd Cycle Studies - Mestrado

Recommended Prerequisites

Recommended prerequesites.

Teaching Methods

Face to face theoretical presentation followed by examples e practical exercises.

Learning Outcomes

To organize budget impact studies. To justify prices and ceilings of reimbursement.

Work Placement(s)

No

Syllabus

To identify the epidemiology of disease (prevalence and incidence) in Portugal. To built a budegt impact study amd toneggocite it with the third payer.

Head Lecturer(s)

António Augusto Miranda Lemos Romão Donato

Assessment Methods

Assessment
Exam: 100.0%

Bibliography

Pauwels K, Huys I, Casteels M, Simoens S. Industry Perspectives on Market Access of Innovative Drugs: TheRelevance for Oncology Drugs. Front Pharmacol. 2016 Jun 1;7:144. doi: 10.3389/fphar.2016.00144.
Bohm N, Bermingham S, Grimsey Jones F, Gonçalves-Bradley DC, Diamantopoulos A, Burton JR, Laing H. TheChallenges of Outcomes-Based Contract Implementation for Medicines in Europe. Pharmacoeconomics. 2022Jan;40(1):13-29.
Antonanzas F, Juárez-Castelló C, Lorente R, Rodríguez-Ibeas R. The Use of Risk-Sharing Contracts in Healthcare:Theoretical and Empirical Assessments. Pharmacoeconomics. 2019 Dec;37(12):1469-1483.